Avenue Therapeutics, Inc.
ATXIOTCHealthcare● Active
$0.31
$-0.04(-12.06%)
Market Cap$1021440
P/E Ratio—
52W High$0.9699
52W Low$0.15
Avenue Therapeutics, Inc.（ATXI）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ATXI · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.40M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $1.40M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 100.00% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $1.04M | $6.64M | $10.36M | $2.70M | $1.25M |
| G&A Expenses | $3.65M | $4.64M | $4.18M | $5.34M | $2.48M |
| Total Operating Expenses | $4.69M | $11.28M | $14.54M | $8.04M | $3.74M |
| Operating Income | ($3.29M) | ($11.28M) | ($14.54M) | ($8.04M) | ($3.74M) |
| Operating Margin %(computed) | -234.05% | — | — | — | — |
| Interest Income | $0.12M | $0.18M | $0.13M | $0.02M | $0.01M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $1.16M | $0.00M |
| Income Before Tax | ($2.95M) | ($11.70M) | ($10.49M) | ($3.60M) | ($3.73M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($2.91M) | ($11.65M) | ($10.38M) | ($3.55M) | ($3.73M) |
| Net Margin %(computed) | -207.19% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.93 | $-0.90 | $-73.60 | $-121.91 | $-3.29 |
| Wtd Avg Shares | 3.13M | 12.95M | 0.14M | 0.03M | 1.13M |
| EBITDA | ($3.29M) | ($11.70M) | $4.05M | ($2.44M) | $0.01M |
| EBITDA Margin %(computed) | -234.05% | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Avenue Therapeutics, Inc.
关于Avenue Therapeutics, Inc.（ATXI）损益表
Avenue Therapeutics, Inc.（ATXI）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，ATXI实现营收$0.00B，毛利润$0.00B（毛利率100.00%），净利润($0.00B)（净利率-207.19%）。
常见问题
ATXI · 4 问Avenue Therapeutics, Inc.（ATXI）2025财年营收为$0.00B，同比up—%。
ATXI revenueATXI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09